Europe — EMA

Octanate (Human Coagulation Factor Viii)

Human Coagulation Factor VIII, the active ingredient in Octanate, is a coagulation factor replacement therapy presented as an intravenous solution for intravenous use.

Human Coagulation Factor Viii

Request sourcing

Pack/s

What is Human Coagulation Factor Viii?

Human Coagulation Factor VIII, the active ingredient in Octanate, is a coagulation factor replacement therapy presented as an intravenous solution for intravenous use. It treats hemophilia A by providing the missing clotting protein in patients with this genetic disorder. GNH USA supplies Octanate as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Octanate as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

What is Human Coagulation Factor Viii used for?

Octanate is a recombinant clotting factor used in the management of bleeding disorders within the hemophilia A pathway.

- Hemophilia A: Provides ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... provides ... ... ... - ... ... ... ... ... ... ...

What are the side effects of Human Coagulation Factor Viii?

The … ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →